ArticleScience advances2025

Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma.

Yao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.